SEC Form 4 · Updated Daily
URGN
— UROGEN PHARMA LTD OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| Schoenberg Mark | Officer | 59,882 | 2026-09-08 | S |
| Smith Jason Drew | Officer | 53,141 | 2026-09-08 | S |
| Robinson James A. Jr. | Director | 8,000 | 2026-08-26 | M |
| Degnan Chris | Officer | 2,280 | 2025-10-08 | S |
| BUTITTA CYNTHIA M | Director | 2,000 | 2025-11-26 | M |
| Holden Stuart | Director | 2,000 | 2025-11-26 | M |
| WEN LEANA | Director | 2,000 | 2025-11-26 | M |
| Wildman Daniel George | Director | 2,000 | 2025-11-26 | M |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-09-08 | Smith Jason Drew | Open-market sale | 1,519 | $42.54 | 53,141 |
| 2026-09-08 | Schoenberg Mark | Open-market sale | 871 | $42.92 | 59,882 |
| 2026-09-07 | Smith Jason Drew | Option exercise (derivative) | 3,334 | $0.00 | 0 |
| 2026-09-07 | Smith Jason Drew | Option exercise | 3,334 | — | 54,660 |
| 2026-09-07 | Schoenberg Mark | Option exercise (derivative) | 1,667 | $0.00 | 0 |
| 2026-09-07 | Schoenberg Mark | Option exercise | 1,667 | — | 60,753 |
| 2026-08-26 | Robinson James A. Jr. | Option exercise (derivative) | 2,000 | $0.00 | 0 |
| 2026-08-26 | Robinson James A. Jr. | Option exercise | 2,000 | — | 8,000 |
| 2026-08-20 | Schoenberg Mark | Open-market sale | 60,677 | $47.05 | 59,086 |
| 2026-07-09 | Schoenberg Mark | Open-market sale | 10,000 | $40.00 | 119,763 |
| 2026-06-22 | Belldegrun Arie | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2026-06-22 | WEN LEANA | Grant / award (derivative) | 8,000 | $0.00 | 8,000 |
| 2026-06-22 | WEN LEANA | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2026-06-22 | BUTITTA CYNTHIA M | Grant / award (derivative) | 8,000 | $0.00 | 8,000 |
| 2026-06-22 | BUTITTA CYNTHIA M | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2026-06-22 | Holden Stuart | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2026-06-22 | Robinson James A. Jr. | Grant / award (derivative) | 8,000 | $0.00 | 8,000 |
| 2026-06-22 | Robinson James A. Jr. | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2026-06-22 | Wildman Daniel George | Grant / award (derivative) | 8,000 | $0.00 | 8,000 |
| 2026-06-22 | Wildman Daniel George | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2026-06-22 | Schoenberg Mark | Open-market sale | 10,000 | $35.01 | 129,763 |
| 2026-06-08 | Schoenberg Mark | Option exercise (derivative) | 10,000 | $0.00 | 0 |
| 2026-06-08 | Schoenberg Mark | Open-market sale | 5,222 | $27.30 | 139,763 |
| 2026-06-08 | Schoenberg Mark | Option exercise | 10,000 | — | 144,985 |
| 2026-05-26 | Robinson James A. Jr. | Option exercise (derivative) | 2,000 | $0.00 | 2,000 |
| 2026-05-26 | Robinson James A. Jr. | Option exercise | 2,000 | — | 6,000 |
| 2026-05-08 | Schoenberg Mark | Open-market sale | 10,000 | $30.00 | 134,985 |
| 2026-02-03 | Schoenberg Mark | Open-market sale | 3,686 | $19.69 | 144,985 |
| 2026-02-03 | Schoenberg Mark | Open-market sale | 1,843 | $19.69 | 148,671 |
| 2026-02-03 | Schoenberg Mark | Open-market sale | 1,844 | $19.69 | 150,514 |
| 2026-02-03 | Smith Jason Drew | Open-market sale | 3,217 | $19.69 | 55,588 |
| 2026-02-03 | Smith Jason Drew | Open-market sale | 1,608 | $19.69 | 51,326 |
| 2026-02-03 | Smith Jason Drew | Open-market sale | 2,654 | $19.69 | 52,934 |
| 2026-01-31 | Degnan Chris | Grant / award (derivative) | 32,609 | $0.00 | 32,609 |
| 2026-01-31 | Schoenberg Mark | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2026-01-31 | Schoenberg Mark | Option exercise (derivative) | 3,334 | $0.00 | 0 |
| 2026-01-31 | Schoenberg Mark | Option exercise (derivative) | 6,666 | $0.00 | 13,334 |
| 2026-01-31 | Schoenberg Mark | Option exercise (derivative) | 3,333 | $0.00 | 3,334 |
| 2026-01-31 | Schoenberg Mark | Option exercise | 3,334 | — | 142,359 |
| 2026-01-31 | Schoenberg Mark | Option exercise | 6,666 | — | 152,358 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.